These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 27532897)

  • 1. Kinetic Analysis of Benign and Malignant Breast Lesions With Ultrafast Dynamic Contrast-Enhanced MRI: Comparison With Standard Kinetic Assessment.
    Abe H; Mori N; Tsuchiya K; Schacht DV; Pineda FD; Jiang Y; Karczmar GS
    AJR Am J Roentgenol; 2016 Nov; 207(5):1159-1166. PubMed ID: 27532897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonmass Enhancement Breast Lesions: Diagnostic Performance of Kinetic Assessment on Ultrafast and Standard Dynamic Contrast-Enhanced MRI in Comparison With Morphologic Evaluation.
    Mori N; Sheth D; Abe H
    AJR Am J Roentgenol; 2020 Aug; 215(2):511-518. PubMed ID: 32452698
    [No Abstract]   [Full Text] [Related]  

  • 3. Fast Temporal Resolution Dynamic Contrast-Enhanced MRI: Histogram Analysis Versus Visual Analysis for Differentiating Benign and Malignant Breast Lesions.
    Mori N; Pineda FD; Tsuchiya K; Mugikura S; Takahashi S; Karczmar GS; Abe H
    AJR Am J Roentgenol; 2018 Oct; 211(4):933-939. PubMed ID: 30063374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-T dynamic contrast-enhanced MRI of the breast: pharmacokinetic parameters versus conventional kinetic curve analysis.
    El Khouli RH; Macura KJ; Kamel IR; Jacobs MA; Bluemke DA
    AJR Am J Roentgenol; 2011 Dec; 197(6):1498-505. PubMed ID: 22109308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrafast Dynamic Contrast-Enhanced Breast MRI: Kinetic Curve Assessment Using Empirical Mathematical Model Validated with Histological Microvessel Density.
    Mori N; Abe H; Mugikura S; Takasawa C; Sato S; Miyashita M; Mori Y; Pineda FD; Karczmar GS; Tamura H; Takahashi S; Takase K
    Acad Radiol; 2019 Jul; 26(7):e141-e149. PubMed ID: 30269956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation between subcentimeter carcinomas and benign lesions using kinetic parameters derived from ultrafast dynamic contrast-enhanced breast MRI.
    Onishi N; Sadinski M; Gibbs P; Gallagher KM; Hughes MC; Ko ES; Dashevsky BZ; Shanbhag DD; Fung MM; Hunt TM; Martinez DF; Shukla-Dave A; Morris EA; Sutton EJ
    Eur Radiol; 2020 Feb; 30(2):756-766. PubMed ID: 31468162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-enhanced magnetic resonance imaging of the breast: the value of pharmacokinetic parameters derived from fast dynamic imaging during initial enhancement in classifying lesions.
    Veltman J; Stoutjesdijk M; Mann R; Huisman HJ; Barentsz JO; Blickman JG; Boetes C
    Eur Radiol; 2008 Jun; 18(6):1123-33. PubMed ID: 18270714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New parameters of ultrafast dynamic contrast-enhanced breast MRI using compressed sensing.
    Honda M; Kataoka M; Onishi N; Iima M; Ohashi A; Kanao S; Nickel MD; Toi M; Togashi K
    J Magn Reson Imaging; 2020 Jan; 51(1):164-174. PubMed ID: 31215107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compressed Sensing for Breast MRI: Resolving the Trade-Off Between Spatial and Temporal Resolution.
    Vreemann S; Rodriguez-Ruiz A; Nickel D; Heacock L; Appelman L; van Zelst J; Karssemeijer N; Weiland E; Maas M; Moy L; Kiefer B; Mann RM
    Invest Radiol; 2017 Oct; 52(10):574-582. PubMed ID: 28463932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The additional utility of ultrafast MRI on conventional DCE-MRI in evaluating preoperative MRI of breast cancer patients.
    Lee SJ; Ko KH; Jung HK; Koh JE; Park AY
    Eur J Radiol; 2020 Mar; 124():108841. PubMed ID: 31981877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrafast Bilateral DCE-MRI of the Breast with Conventional Fourier Sampling: Preliminary Evaluation of Semi-quantitative Analysis.
    Pineda FD; Medved M; Wang S; Fan X; Schacht DV; Sennett C; Oto A; Newstead GM; Abe H; Karczmar GS
    Acad Radiol; 2016 Sep; 23(9):1137-44. PubMed ID: 27283068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the Number of Iterations in Compressed Sensing Reconstruction on Ultrafast Dynamic Contrast-enhanced Breast MR Imaging.
    Sagawa H; Kataoka M; Kanao S; Onishi N; Nickel MD; Toi M; Togashi K
    Magn Reson Med Sci; 2019 Jul; 18(3):200-207. PubMed ID: 30416179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of electric properties tomography (EPT) for differentiating benign from malignant breast lesions: comparison with standard dynamic contrast-enhanced MRI.
    Mori N; Tsuchiya K; Sheth D; Mugikura S; Takase K; Katscher U; Abe H
    Eur Radiol; 2019 Apr; 29(4):1778-1786. PubMed ID: 30255252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic approach for dynamic breast MRI to indicate signal intensity time curves of benign and malignant lesions by using the tumor flow residence time.
    Renz DM; Diekmann F; Schmitzberger FF; Pietsch H; Fallenberg EM; Durmus T; Huppertz A; Böttcher J; Bick U; Hamm B; Lawaczeck R
    Invest Radiol; 2013 Feb; 48(2):69-78. PubMed ID: 23262793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast DCE-MRI: influence of postcontrast timing on automated lesion kinetics assessments and discrimination of benign and malignant lesions.
    Partridge SC; Stone KM; Strigel RM; DeMartini WB; Peacock S; Lehman CD
    Acad Radiol; 2014 Sep; 21(9):1195-203. PubMed ID: 24998690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion-weighted imaging improves the diagnostic accuracy of conventional 3.0-T breast MR imaging.
    Ei Khouli RH; Jacobs MA; Mezban SD; Huang P; Kamel IR; Macura KJ; Bluemke DA
    Radiology; 2010 Jul; 256(1):64-73. PubMed ID: 20574085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single bolus split dynamic MRI: Is the combination of high spatial and dual-echo high temporal resolution interleaved sequences useful in the differential diagnosis of breast masses?
    Grøvik E; Bjørnerud A; Kurz KD; Kingsrød M; Sandhaug M; Storås TH; Gjesdal KI
    J Magn Reson Imaging; 2015 Jul; 42(1):180-7. PubMed ID: 25211038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of gadoteric acid and gadobutrol for detection as well as morphologic and dynamic characterization of lesions on breast dynamic contrast-enhanced magnetic resonance imaging.
    Renz DM; Durmus T; Böttcher J; Taupitz M; Diekmann F; Huppertz A; Pfeil A; Maurer MH; Streitparth F; Bick U; Hamm B; Fallenberg EM
    Invest Radiol; 2014 Jul; 49(7):474-84. PubMed ID: 24637587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI-detected suspicious breast lesions: predictive values of kinetic features measured by computer-aided evaluation.
    Wang LC; DeMartini WB; Partridge SC; Peacock S; Lehman CD
    AJR Am J Roentgenol; 2009 Sep; 193(3):826-31. PubMed ID: 19696298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic contrast-enhanced magnetic resonance imaging of breast tumors at 3 and 7 T: a comparison.
    Gruber S; Pinker K; Zaric O; Minarikova L; Chmelik M; Baltzer P; Boubela RN; Helbich T; Bogner W; Trattnig S
    Invest Radiol; 2014 May; 49(5):354-62. PubMed ID: 24619208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.